Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity

GLIA

Volumn 55, Issue 5, 2007, Pages 463-472

  Du, Yangzhou ^a   Chen, Christopher P ^a   Tseng, Chia Yi ^a   Eisenberg, Yuval ^a   Firestein, Bonnie L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Astrocytes; EAAT; Neuroprotection

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; URIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; IN VITRO STUDY; MACROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; GLUTAMIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; SPINAL CORD; URIC ACID;

EID: 33847745017     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20472     Document Type: Article

References (39)

1. Becker BF. 1993. Towards the physiological function of uric acid. J Free Radic Biol Med 14:615-631.
2. Carriedo SG, Yin HZ, Weiss JH. 1996. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16:4069-4079.
3. Choi DW. 1996. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6:667-672.
4. Dhandapani K, Brann D. 2003. Neuroprotective effects of estrogen and tamoxifen in vitro: A facilitative role for glia? Endocrine 21:59-66.
5. Diaz Z, Assaraf MI, Miller WH Jr, Schipper HM. 2005. Astroglial cytoprotection by erythropoietin pre-conditioning: Implications for ischemic and degenerative CNS disorders. J Neurochem 93:392-402.
6. Doppenberg EM, Choi SC, Bullock R. 1997. Clinical trials in traumatic brain injury. What can we learn from previous studies? Ann NY Acad Sci 825:305-322.
7. Dougherty KD, Dreyfus CF, Black IB. 2000. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis 7(6, Part B):574-585.
8. Faden AI, Ellison JA, Noble LJ. 1990. Effects of competitive and noncompetitive NMDA receptor antagonists in spinal cord injury. Eur J Pharmacol 175:165-174.
9. Faden AJ, Lemke M, Simon RP, Noble LJ. 1988. N-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomic, and neurochemical studies. J Neurotrauma 5:33-45.
10. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143-2155.
11. Fryer HJ, Knox RJ, Strittmatter SM, Kalb RG. 1999. Excitotoxic death of a subset of embryonic rat motor neurons in vitro. J Neurochem 72:500-513.
12. Gomez-Pinilla F, Tram H, Cotman CW, Nieto-Sampedro M. 1989. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp Neurol 104:118-124.
13. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H. 1998. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 95:675-680.
14. Hulsebosch CE. 2002. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26:238-255.
15. Keynes RG, Garthwaite J. 2004. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 4:179-191.
16. Lin Y, Fossom LH, Skolnick P, Long JB. 1998. Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons. Eur J Pharmacol 356:255-260.
17. Liu D, Thangnipon W, McAdoo DJ. 1991. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 547:344-348.
18. Liu D, Xu GY, Pan E, McAdoo DJ. 1999. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 93:1383-1389.
19. Liu S, Ruenes GL, Yezierski RP. 1997. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res 756:160-167.
20. Liuzzi FJ, Lasek RJ. 1987. Astrocytes block axonal regeneration in mammals by activating the physiological stop pathway. Science 237:642-645.
21. McAdoo DJ, Xu GY, Robak G, Hughes MG. 1999. Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp Neurol 159:538-544.
22. McCarthy KD, deVellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
23. Regan RF. 1996. The vulnerability of spinal cord neurons to excitotoxic injury: Comparison with cortical neurons. Neurosci Lett 213:9-12.
24. Rosenberg PA, Amin S, Leitner M. 1992. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci 12:56-61.
25. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. 1993. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90:6591-6595.
26. Rudge JS, Silver J. 1990. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10:3594-3603.
27. Ryan M, Grayson L, Clarke DJ. 1997. The total antioxidant capacity of human serum measured using enhanced chemiluminescence is almost completely accounted for by urate. Ann Clin Biochem 34(Part 6):688-689.
28. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC. 2005. Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci USA 102:3483-3488.
29. Silva GA, Theriault E, Mills LR, Pennefather PS, Feeney CJ. 1999. Group I and II metabotropic glutamate receptor expression in cultured rat spinal cord astrocytes. Neurosci Lett 263:117-120.
30. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5:146-156.
31. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA. 2000. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333-337.
32. Trackey JL, Uliasz TF, Hewett SJ. 2001. SIN-1-induced cytotoxicity in mixed cortical cell culture: Peroxynitrite-dependent and -independent induction of excitotoxic cell death. J Neurochem 79:445-455.
33. Vera-Portocarrero LP, Mills CD, Ye Z, Fullwood SD, McAdoo DJ, Hulsebosch CE, Westlund KN. 2002. Rapid changes in expression of glutamate transporters after spinal cord injury. Brain Res 927:104-110.
34. Wrathall JR, Teng YD, Marriott R. 1997. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol 145(2, Part 1):565-573.
35. Wu H, Friedman WJ, Dreyfus CF. 2004. Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals. J Neurosci Res 76:76-85.
36. Xu GY, Hughes MG, Zhang L, Cain L, McAdoo DJ. 2005. Administration of glutamate into the spinal cord at extracellular concentrations reached post-injury causes functional impairments. Neurosci Lett 384:271-276.
37. Yang HY, Lieska N, Shao D, Kriho V, Pappas GD. 1994. Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas. Mol Chem Neuropathol 21:155-176.
38. Yin HZ, Park DD, Lindsay AD, Weiss JH. 1995. Spinal cord neurons are vulnerable to rapidly triggered kainate neurotoxicity in vitro. Brain Res 689:265-270.
39. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. 1998. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53: 613-625.